There are a number of areas where pharmacy benefit managers can help support employers with the high-cost of specialty pharmacy drugs, but so far they have only been doing a good job in some priority areas, said Bruce Sherman, MD, FCCP, FACOEM.
There are a number of areas where pharmacy benefit managers (PBMs) can help support employers with the high-cost of specialty pharmacy drugs, but so far they have only been doing a good job in some priority areas, said Bruce Sherman, MD, FCCP, FACOEM, of Case Western Reserve, University School of Medicine and medical director of Population Health and Management Exchange Solutions with Buck Consultants at Xerox.
Transcript (slightly modified)
How can pharmacy benefit managers help employers get a grasp on specialty drug spending?
The issue for employers is that there is an ever-growing and expansive pipeline of specialty pharmacy drugs, and as such employers wil certainly benefit from support from the PBMs to control costs. To that end, the PBMs can certainly help by ensuring that they take as supportive of a role as they can in terms of ensuring that the right patient gets the right drug, at the right time, at the right cost, and in the right setting.
Those are really the primary group of targets. To this point, PBMs have been doing a reasonable job in some of those areas, but not all.
Inside the Center's MDD Value Model and Its Use of Dynamic Pricing
May 13th 2025Larragem Raines, MS, of the Center for Innovation & Value Research, discusses the organization's major depressive disorder (MDD) open-source value model, dynamic pricing, and the future role of artificial intelligence in care.
Listen
Real-World Data Show Bevacizumab Benefits Only High-Risk Patients With Epithelial Ovarian Cancer
May 13th 2025In line with previous clinical trial findings, real-world data show that bevacizumab improves outcomes in patients with epithelial ovarian cancer and high-risk prognostic factors.
Read More